Centiva Capital, LP Abbott Laboratories Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Abbott Laboratories stock. As of the latest transaction made, Centiva Capital, LP holds 18,502 shares of ABT stock, worth $2.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

18,502

Previous 21,500 13.94%

Holding current value

$2.1 Million

Previous $2.23 Million 5.6%

% of portfolio

0.04%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $2.41 Million - $2.84 Million	-24,036 Reduced 56.5%	18,502 $2.11 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $3.06 Million - $3.42 Million	30,410 Added 250.74%	42,538 $4.42 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.33 Million - $1.47 Million	12,128 New	12,128 $1.38 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $1.37 Million - $1.64 Million	14,341 New	14,341 $1.39 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $1.04 Million - $1.22 Million	-10,972 Reduced 99.66%	37 $4,000
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $289,602 - $335,305	-2,993 Reduced 21.38%	11,009 $1.07 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $607,622 - $734,421	5,953 Added 73.96%	14,002 $1.52 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $1.34 Million - $1.64 Million	-11,773 Reduced 59.39%	8,049 $953,000
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $2.29 Million - $2.8 Million	19,822 New	19,822 $2.79 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $670,285 - $789,022	-6,336 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $1.21 Million - $1.43 Million	-11,120 Reduced 63.7%	6,336 $759,000
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $799,890 - $871,651	7,618 Added 77.43%	17,456 $1.91 Million
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $252,651 - $306,826	-2,757 Reduced 21.89%	9,838 $1.07 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $964,399 - $1.23 Million	12,595 New	12,595 $1.15 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $3.04 Million - $4.45 Million	-48,446 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $1.59 Million - $1.77 Million	20,294 Added 72.09%	48,446 $4.21 Million
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $2.3 Million - $2.5 Million	28,152 New	28,152 $2.36 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Abbott Laboratories Transaction History